LLMpediaThe first transparent, open encyclopedia generated by LLMs

Louis Ignarro

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 49 → Dedup 20 → NER 5 → Enqueued 4
1. Extracted49
2. After dedup20 (None)
3. After NER5 (None)
Rejected: 15 (not NE: 15)
4. Enqueued4 (None)
Similarity rejected: 1
Louis Ignarro
NameLouis Ignarro
CaptionLouis Ignarro in 2008
Birth date31 May 1941
Birth placeBrooklyn, New York, U.S.
NationalityAmerican
FieldsPharmacology
WorkplacesUCLA, Tulane University, Geigy
Alma materColumbia University, University of Minnesota
Known forDiscovery of nitric oxide as a signaling molecule
PrizesNobel Prize in Physiology or Medicine (1998), Basic Research Prize of the American Heart Association

Louis Ignarro is an American pharmacologist renowned for his pivotal research on the biological role of nitric oxide. His groundbreaking work demonstrated that this gaseous molecule acts as a crucial signaling agent in the cardiovascular system, influencing vasodilation and regulating blood pressure. This discovery, which earned him the Nobel Prize in Physiology or Medicine in 1998, revolutionized the understanding of cellular communication and led to significant advances in treating heart disease. He is a distinguished professor at the UCLA School of Medicine and has received numerous prestigious awards for his scientific contributions.

Early life and education

Louis Ignarro was born in Brooklyn, a borough of New York City, to Italian immigrant parents. He developed an early interest in science and chemistry, which he pursued through his undergraduate studies. He earned his Bachelor of Science degree in pharmacy from Columbia University in 1962, where he was first introduced to the foundational principles of pharmacology and biochemistry. He then continued his academic training at the University of Minnesota, where he received his Ph.D. in pharmacology in 1966. His doctoral research focused on the mechanisms of drug action, laying the groundwork for his future investigations into cellular signaling pathways.

Career and research

Following his Ph.D., Ignarro began his postdoctoral fellowship at the National Institutes of Health in Bethesda, Maryland. He subsequently held a research position at the pharmaceutical company Geigy before transitioning to academia. He served as a professor at the Tulane University School of Medicine, where he conducted seminal research on cyclic GMP and smooth muscle relaxation. In 1985, he joined the faculty at the UCLA School of Medicine, where he continued his pioneering work. His research, conducted in parallel with that of Robert F. Furchgott and Ferid Murad, conclusively identified nitric oxide as the elusive endothelium-derived relaxing factor (EDRF), a discovery that explained how acetylcholine and other substances cause blood vessels to dilate.

Nobel Prize in Physiology or Medicine

In 1998, Louis Ignarro was jointly awarded the Nobel Prize in Physiology or Medicine with Robert F. Furchgott and Ferid Murad. The Royal Swedish Academy of Sciences recognized their independent but complementary discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system. Ignarro's key contribution was providing direct chemical and pharmacological evidence that EDRF was indeed nitric oxide, a finding he presented at a landmark conference at the Mayo Clinic in 1986. This Nobel Prize-winning work transformed nitric oxide from a mere environmental pollutant into a fundamental biological mediator, opening new avenues for drug development, including the creation of sildenafil (Viagra) for erectile dysfunction and novel therapies for pulmonary hypertension and heart failure.

Awards and honors

Beyond the Nobel Prize, Ignarro has received extensive recognition from the international scientific community. He was a co-recipient of the prestigious Basic Research Prize of the American Heart Association. He has been elected a member of the United States National Academy of Sciences and the American Academy of Arts and Sciences, honors reflecting his profound impact on biomedical science. Other significant accolades include the Rolf Luft Award from the Karolinska Institute in Sweden and the Distinguished Scientist Award from the American Heart Association. His work has also been recognized with honorary doctorates from several universities around the world.

Personal life

Louis Ignarro is known for his dedication to public science education, frequently lecturing on the health benefits of nitric oxide and promoting cardiovascular wellness. He has authored several books for a general audience, including "NO More Heart Disease." He maintains an active role at UCLA, mentoring future generations of scientists in the Department of Molecular and Medical Pharmacology. A passionate advocate for healthy living, he often discusses the role of diet and exercise in enhancing the body's natural production of beneficial nitric oxide.

Category:American pharmacologists Category:Nobel laureates in Physiology or Medicine Category:University of California, Los Angeles faculty Category:Columbia University alumni Category:University of Minnesota alumni Category:1941 births Category:Living people